LOX inhibitors enhanced phosphatase and tensin homolog deleted on chromosome 10 (PTEN) activity to inhibit the phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (AKT) pathway, thus promoting cell survival and inhibiting apoptosis, which slows CRC progression 42. The gene discussed is AKT1; the disease is colorectal carcinoma.